Skip to main content

Table 1 Patient characteristics and sIL-2R measurements

From: Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes

 

controls

all patients

stage of cirrhosis

no cirrh.

Child A

Child B

Child C

n

41

71

23

21

13

14

sex male/ female n

20/21

37/34

11/12

8/13

8/5

10/4

age yrs

35

54

43

61

63

53

median (range)

(18–65)

(17–74)

(17–64)

(30–74)

(28–74)

(34–73)

disease etiology n

n.a.

     

 virus hepatitis

 

24

11

8

5

0

 biliary/autoimmune

 

8

2

4

1

1

 alcohol

 

21

3

5

3

10

 other origin

 

18

7

4

4

3

MELD score

n.a.

n.a.

n.a.

8

11

17

median (range)

(6–17)

(7–16)

(12–28)

ALT U/L

19

41

64

34

36

29

median (range)

(5–54)

(7–568)

(15–568)

(8–188)

(7–92)

(14–261)

bilirubin mg/dL

n.a.

1.3

0.7

0.9

1.6

5.1

median (range)

(0.2-12.5)

(0.4-8.7)

(0.2-8.9)

(0.2-9.0)

(1.8-12.5)

albumin mg/dL

n.a.

38

45

40

27

27

median (range)

(12–50)

(40–50)

(30–43)

(12–38)

(22–31)

international normalized

n.a.

1.07

0.98

1.06

1.20

1.43

ratio median (range)

(0.92-1.69)

(0.93-1.12)

(0.92-1.32)

(0.99-1.39)

(1.18-1.69)

hyaluronic acid μg/l

n.a.

190

28

205

305

800

median (range)

(10–800)

(10–210)

(36–800)

(140–800)

(190–800)

procollagen-III-peptide

584

1135

973

990

1710

2500

median (range) μg/l

(157–1160)

(470–6560)

(470–1750)

(589–1930)

(639–2630)

(1010–6560)

creatinine mg/dL

0.7

0.7

0.7

0.7

0.6

0.8

median (range)

(0.6-0.9)

(0.3-2.4)

(0.4-1.0)

(0.4-1.9)

(0.4-1.8)

(0.3-2.4)

cystatin C mg/L

n.a.

0.98

0.80

1.01

1.20

1.46

median (range)

(0.40-2.81)

(0.40-1.16)

(0.69-2.81)

(0.74-2.78)

(0.80-2.41)

GFR [cyst. C] ml/min

n.a.

88

123

83

64

45

median (range)

(15–395)

(66–395)

(15–158)

(15–140)

(19–123)

total monocytes x106/L

416

490

419

426

477

816

median (range)

(165–852)

(70–2208)

(70–860)

(296–1332)

(162–2208)

(294–1180)

CD14++CD16- monocytes

386

442

384

387

425

714

x106/L median (range)

(155–748)

(65–2101)

(65–807)

(250–1155)

(142–2101)

(257–1089)

CD14+CD16+ monocytes

32.4

46

40

45

67

92

x106/L median (range)

(10–108)

(4.6-175)

(4.6-158)

(26–175)

(18–135)

(6.4-153)

sIL-2R kU/L

444

818

374

764

1101

1029

median (range)

(14–1193)

(39–3976)

(204–1795)

(39–3976)

(317–2494)

(370–3350)

  1. ALT, alanine aminotransferase activity; GFR, glomerular filtration rate; MELD, model of end-stage liver disease; n.a., not applicable / not assessed; sIL-2R, soluble interleukin-2 receptor.